Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 20, 2025
Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 13, 2021
Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Blue California Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 21, 2020
Lead Product(s) : L-Ergothioneine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Blue California Company
Deal Size : Inapplicable
Deal Type : Inapplicable